The New PhRMA Code and Beyond: Federal & State Laws are Eclipsing Self-Regulation

At a recent ExL Pharma conference industry leaders from pharma and the vendor community reviewed the impact on

Pharma Marketing News Vol. 8, #5

Welcome to the May 2009 issue of Pharma Marketing News.

The Empowered Patient: What It Means for Pharma Marketers

This article presents a case for the drug industry to adopt a patient-centric model in which pharma companies can develop unique expertise in decoding the behavior, needs, motivations of empowered patients and then use this knowledge as the basis for helping healthcare professionals and payers to put into place programs that achieve better patient outcomes.

Pharma Marketing News Vol. 8, #7

Welcome to the August 2009 issue of Pharma Marketing News.

How Should Pharma Engage in Social Networks?: Thoughts on Best Practices

Each pharmaceutical company should have its own guidelines for best practices in the social media space. To assist in that discussion, Pharma Marketing News hosted a survey to explores issue relating to pharma advertising and engagement in social networks. This article summarizes the results of that survey.

Pharma Marketing News Vol. 8, #8

Welcome to the September 2009 issue of Pharma Marketing News.

Building the Optimal Service Model: Creating the Right Physician Experiences to Drive Business

This article presents a summary of a recent TNS Healthcare webinar and personal conversations with presenters conducted beforehand. Included are NEW research results about how US and European physicians rate pharmaceutical companies against a number of customer value points that are important in achieving success with the new sales model.

The View From ePharma Summit: Practicing What Was Being Preached!

This article is a compilation of summaries of presentations made at the 2009 ePharma Summit. Included are highlights posted to the ePharma Summit and other blogs during the conference and insights on epharma marketing issues provided by several conference speakers and attendees.

Developing Guidelines for Pharma’s Use of the Internet & Social Media: Whatever! A Call...

Shouldn't we make sure that when it comes time for the FDA to actually create a guidance document on social media that it does it with input from ALL stakeholders? Survey results.

Pharma Marketing News Vol. 8, #3

Welcome to the March 2009 issue of Pharma Marketing News.
- Advertisement -